Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Optometry
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Power List / 2024 / Honorees / Byron L Lam

Byron L. Lam

  • Profile

About Byron L. Lam

Mark J. Daily Professor of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Florida, USA

Make a bold prediction for the future of ophthalmology.

I have been fortunate to have been a clinical scientist in inherited retinal disease (IRD) and neuro-ophthalmology. The power of genetic testing has blossomed, and I believe that modifying genetic factors in IRD will be discovered; moreover, novel subjective imaging and functional modalities will serve as better outcome measures in IRD clinical trials. Combination treatments with more than one modality, such as gene therapy, in the treatment of IRD will be common. Prophylactic gene therapy of unaffected carriers of Leber hereditary optic neuropathy to decrease disease penetrance will be the norm to achieve better outcomes.

If you weren’t an ophthalmologist, what would you be doing instead?

I decided to pursue ophthalmology at the end of my third year in medical school, which is rather late by today’s standards. I think I would have been a physicist if I had not gone into medicine.

How do you think AI and machine learning will impact ophthalmology?

AI will be transformative in the diagnosis and treatment of ophthalmic diseases by increasing the accuracy and the speed of clinical assessments. Ultimately, AI will improve visual health tremendously; it will increase the volume of research, and as newer diagnoses and treatments are discovered, this will translate into a need for more ophthalmologists.

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: